Huntsman Ronald Kirk 4
4 · Vivos Therapeutics, Inc. · Filed Jun 20, 2023
Insider Transaction Report
Form 4
Huntsman Ronald Kirk
DirectorChief Executive Officer10% Owner
Transactions
- Purchase
Common Stock
2023-06-20$0.53/sh+14,000$7,420→ 86,521 total
Holdings
- 1,740,000(indirect: See footnote)
Common Stock
Footnotes (1)
- [F1]Shares held by Coronado V Partners, LLC, of which the reporting person is a member and manager.